Search Results
Screening for myeloma precursors: iStopMM, PROMISE, and the questions they have raised
First results of PROMISE: MGUS screening in a high-risk population
Updates from the iStopMM study
How to Catch Myeloma Early Through Cancer Screening & Newer Tech | Dr. Joseph Mikhael
Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention
Blood Cancer: Higher rates of precursor in high-risk individuals
The Promise Study: How a Blood Test Can Detect, Intercept, and Potentially Eliminate Cancer
Autoimmune Diseases Are Not Associated with MGUS: Results of the Population-Based iStopMM
Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from iStopMM
The Truth About MGUS
Are MGUS patients at higher risk of getting severely ill from COVID-19?
Facebook Live 9/7/22: FAQs on Multiple Myeloma Precursor Conditions